These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J. Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [Abstract] [Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [Abstract] [Full Text] [Related]
6. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Sumida T, Yoshida S, Matsuura E, Ikehara S, Koike T. J Immunol; 1992 Aug 01; 149(3):1063-8. PubMed ID: 1634762 [Abstract] [Full Text] [Related]
7. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. J Clin Invest; 2002 Mar 01; 109(6):797-804. PubMed ID: 11901188 [Abstract] [Full Text] [Related]
8. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids. Takeya H, Mori T, Gabazza EC, Kuroda K, Deguchi H, Matsuura E, Ichikawa K, Koike T, Suzuki K. J Clin Invest; 1997 May 01; 99(9):2260-8. PubMed ID: 9151800 [Abstract] [Full Text] [Related]
9. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome. Katzav A, Litvinjuk Y, Pick CG, Blank M, Shoenfeld Y, Sirota P, Chapman J. Behav Brain Res; 2006 May 15; 169(2):289-93. PubMed ID: 16530276 [Abstract] [Full Text] [Related]
10. Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome. Blank M, Waisman A, Mozes E, Koike T, Shoenfeld Y. Int Immunol; 1999 Dec 15; 11(12):1917-26. PubMed ID: 10590257 [Abstract] [Full Text] [Related]
13. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Tzang BS, Lee YJ, Yang TP, Tsay GJ, Shi JY, Tsai CC, Hsu TC. Clin Chim Acta; 2007 Jul 15; 382(1-2):31-6. PubMed ID: 17451664 [Abstract] [Full Text] [Related]
14. Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS. Levy Y, Sherer Y, Mathieu A, Cauli A, Passiu G, Sanna G, Janackovic Z, Blank M, Shoenfeld Y. Clin Exp Rheumatol; 2000 Jul 15; 18(4):479-84. PubMed ID: 10949723 [Abstract] [Full Text] [Related]
15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr 15; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
20. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Yodfat O, Blank M, Krause I, Shoenfeld Y. Clin Immunol Immunopathol; 1996 Jan 15; 78(1):14-20. PubMed ID: 8599879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]